Skip to content

Imbruvica

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2023

    AbbVie files patent lawsuit against BeiGene over Brukinsa

    AbbVie’s Pharmacyclics unit filed a lawsuit against BeiGene in federal court in Delaware, alleging that BeiGene’s Brukinsa infringes a patent on AbbVie’s Imbruvica. AbbVie sought a declaratory judgment of infringement and damages; BeiGene said it would vigorously defend against the allegations.